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Abstract
© 2017 Khaiboullina,  Levis,  Morzunov,  Martynova,  Anokhin,  Gusev,  St  Jeor,  Lombardi  and
Rizvanov. Hantavirus infection is an acute zoonosis that clinically manifests in two primary
forms, hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome
(HPS). HFRS is endemic in Europe and Russia, where the mild form of the disease is prevalent in
the Tatarstan region. HPS is endemic in Argentina, as well as other countries of North and South
American. HFRS and HPS are usually acquired via the upper respiratory tract by inhalation of
virus-contaminated  aerosol.  Although  the  pathogenesis  of  HFRS  and  HPS  remains  largely
unknown, postmortem tissue studies have identified endothelial cells as the primary target of
infection. Importantly, cell damage due to virus replication, or subsequent tissue repair, has not
been documented. Since no single factor has been identified that explains the complexity of
HFRS or HPS pathogenesis, it has been suggested that a cytokine storm may play a crucial role
in the manifestation of both diseases. In order to identify potential serological markers that
distinguish HFRS and HPS, serum samples collected during early and late phases of the disease
were analyzed for 48 analytes using multiplex magnetic bead-based assays. Overall, serum
cytokine profiles associated with HPS revealed a more pro-inflammatory milieu as compared to
HFRS. Furthermore, HPS was strictly characterized by the upregulation of cytokine levels, in
contrast to HFRS where cases were distinguished by a dichotomy in serum cytokine levels. The
severe form of hantavirus zoonosis, HPS, was characterized by the upregulation of a higher
number of cytokines than HFRS (40 vs 21). In general, our analysis indicates that, although HPS
and HFRS share many characteristic features, there are distinct cytokine profiles for these
diseases. These profiles suggest a strong activation of an innate immune and inflammatory
responses are associated with HPS, relative to HFRS, as well as a robust activation of Th1-type
immune responses. Finally, the results of our analysis suggest that serum cytokines profiles of
HPS and HFRS cases are consistent with the presence of  extracellular matrix degradation,
increased mononuclear leukocyte proliferation, and transendothelial migration.
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